Clinical Trials Sponsored by National Institute on Drug Dependence, China

Total 2526 results

National Institute on Drug Dependence, China

Completed

Methadone Induced Memory Retrieval-extinction Procedure in Heroin Addicts

Heroin Dependence
National Institute on Drug Dependence, China

Completed

Effect of Stress on Heroin-Related Memory Retrieval

Heroin Dependence | Learning and Memory

China
National Institute on Drug Dependence, China
Man Wellness Center, Beijing, China

Not yet recruiting

MHealth Intervention of HIV and STDs Partner Notification for MSM

Sexually Transmitted Diseases | HIV/AIDS | Prevention
National Institute on Drug Dependence, China
National Natural Science Foundation of China

Completed

Incubation of Alcohol Craving During Abstinence

Alcohol Dependence
National Institute on Drug Dependence, China
Bronx VA Medical Center

Completed

Association of Functional COMT Val108/Met Polymorphism With Smoking Cessation in Nicotine Replacement Therapy

Nicotine Dependence
National Institute on Drug Dependence, China
Peking University; Shengjing Hospital

Recruiting

Adjunctive Everolimus Treatment of Refractory Epilepsy

Epilepsy

China
Peking University Sixth Hospital
National Institute on Drug Dependence, China

Completed

Effects of Escitalopram on the Sleep EEG Power in Patients With Major Depressive Disorder

Depressive Disorder, Major
National Institute on Drug Dependence, China
Peking University Sixth Hospital; Wuhan Wuchang Hospital

Unknown

Neurocognitive Functions of Recovered COVID-19 Patients

Covid-19 | Cognition

China
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

Methamphetamine-dependence | Methamphetamine Abuse
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Bupropion for Treating Nicotine Dependence in Young People

Tobacco Use Disorder | Tobacco Use Cessation

United States
National Institute on Drug Abuse (NIDA)

Completed

A Multi-Center Trial of Nepicastat for Cocaine Dependence

Cocaine Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Bupropion for Smokers Recovering From Alcohol Dependence

Alcohol-Related Disorders | Smoking Cessation

United States
National Institute on Drug Abuse (NIDA)

Completed

Topiramate for the Treatment of Methamphetamine Dependence - 1

Methamphetamine

United States
National Institute on Drug Abuse (NIDA)

Terminated

Ph1 Marinol Interaction Study - Part 1 - 1

Marijuana Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

Selegiline in Outpatient Treatment for Cocaine Dependence - 1

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Naltrexone Augmentation of Nicotine Patch Therapy - 1

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1

Cocaine-Related Disorders | Opiate Dependence
National Institute on Drug Abuse (NIDA)

Completed

Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens

Opioid-Related Disorders | Heroin Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1

Heroin Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluating Alternative Aftercare Models for Ex-offenders

Drug/Substance Abuse/Addiction | Alcohol Abuse/Addiction

United States
National Institute on Drug Abuse (NIDA)

Completed

Safety, Tolerability and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Dependence

Tobacco Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia

Schizophrenia | Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

The Genetic Basis for Vulnerability to Substance Abuse

Substance Abuse

United States
National Institute on Drug Abuse (NIDA)

Completed

Tramadol to Reduce Opioid Withdrawal Symptoms

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Smoking Cessation Treatment - 1

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Bupropion for the Treatment of Methamphetamine Dependence - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Terminated

Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1

Schizophrenia | Tobacco Use Disorder | Tobacco Use Cessation
National Institute on Drug Abuse (NIDA)

Completed

Effects of Fatty Acid Supplementation on Substance Dependent Individuals

Substance-related Disorders
National Institute on Drug Abuse (NIDA)

Completed

Addition of Naltrexone to Methadone Taper

Substance-Related Disorders | Opioid-Related Disorders | Heroin Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

Baclofen for the Treatment of Cocaine Dependence - 1

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Interaction Between Cocaine and Quetiapine - 1

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Terminated

Interactions Between Intravenous (IV) Cocaine and Lofexidine

Cocaine Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Assessment of Potential Interactions Between Cocaine and Tolcapone - 1

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke

Psychotic Disorders | Schizophrenia | Tobacco-Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Unknown

Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals (MAP)

HIV Infections | HIV Infection

United States
National Institute on Drug Abuse (NIDA)

Unknown

Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users

HIV Infection | Hepatitis B Infection | Hepatitis C Infection

United States
National Institute on Drug Abuse (NIDA)

Unknown

Cognitive Correlates of Substance Abuse - 11

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Student Athlete Testing Using Random Notification (SATURN)

Substance Abuse | Drug Abuse | Alcohol Abuse

United States
National Institute on Drug Abuse (NIDA)

Unknown

Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder

Bipolar Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Using Smokeless Tobacco Products With Lower Nicotine Levels to Reduce Negative Effects of Smokeless Tobacco Use (Brandswitch)

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Combination Tablet Feasibility - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Three Strategies for Implementing Motivational Interviewing on Medical Inpatient Units

See One | Do One | Order One

United States
National Institute on Drug Abuse (NIDA)

Completed

Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana

Smoking, Marijuana

United States

Clinical Trials Sponsored by National Institute on Drug Dependence, China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations